Home > Site Map > Recommendations > L > LDN - Low Dose Naltrexone
 

 
LDN - Low Dose Naltrexone
 
Its only interaction with other drugs is with narcotics (such as morphine, Demerol and Percocet), which it briefly blocks. The following diseases have been benefited by LDN use according to Dr. Bernard Bihari, MD.
  • HIV/AIDS
  • Pancreatic Cancer
  • Prostate Cancer
  • Carcinoid Cancer
  • Hodgkin's Disease
  • Multiple Sclerosis (MS)
  • Non-Hodgkin's Lymphomas
  • Rheumatoid Arthritis
  • Lupus (SLE)
  • Lymphocytic Leukemia
  • Psoriasis
  • Neuroblastoma
  • Behcet's Disease
  • Colorectal Cancer
  • Chronic Fatigue Syndrome
Indeed, research by others has found opioid (endorphin) receptors in brain tumors (both astrocytoma and glioblastoma), breast cancer, endometrial cancer, head and neck squamous cell carcinoma, myeloid leukemia, lung cancer (both small cell and non- small cell), and in neuroblastoma. These findings suggest the possibility for a beneficial effect in a wide variety of other cancers.
 
LDN - Low Dose Naltrexone benefits or hinders:
 
AIDS
Carcinoid Cancer
Chronic Lymphocytic Leukemia (CLL)
Colon Cancer
Crohn's Disease
Hodgkin's Lymphoma
Lung Cancer
Non-Hodgkin's Lymphoma
Ovarian Cancer
Pancreatic Cancer
Psoriasis
Sarcoidosis
Ulcerative Colitis